SB Technology Holdings, Inc.
$0.40+48.15%(+$0.13)
TickerSpark Score
32/100
60
Valuation
20
Profitability
15
Growth
36
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VGLS research report →
52-Week Range47% of range
Low $0.14
Current $0.40
High $0.70
Companywww.vglifesciences.com
SB Technology Holdings, Inc. is a holding company. It is restructuring its business.
- CEO
- William Farrand
- IPO
- 2026
- Employees
- 1
- HQ
- New York, NY, US
Price Chart
-10.07% · this period
Valuation
- Market Cap
- $421.91K
- P/E
- -1.19
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.78
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 0.00%
- ROIC
- 0.00%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-355,176 · -116.77%
- EPS
- $-0.40 · -120.00%
- Op Income
- $-296,553
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.70
- 52W Low
- $0.14
- 50D MA
- $0.46
- 200D MA
- $0.46
- Beta
- -72.29
- Avg Volume
- 9.26K
Get TickerSpark's AI analysis on VGLS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our VGLS Coverage
We haven't published any research on VGLS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate VGLS Report →Similar Companies
AAGH+0.00%
America Great Health
$0.00
NMLSF-12.77%
Restart Life Sciences Corp.
$0.06
AGNPF-4.20%
Algernon Pharmaceuticals Inc.
$0.28
IBOGF+0.73%
Universal Ibogaine Inc.
$0.03
RNUGF+0.00%
ReNeuron Group plc
$0.00
ADXS+0.00%
Ayala Pharmaceuticals, Inc.
$0.60
APLIF+0.00%
Appili Therapeutics Inc.
$0.02
HESG+0.00%
Health Sciences Group, Inc.
$0.00